Add like
Add dislike
Add to saved papers

A comparative analysis of attitudes toward genome-edited food among Japanese public and scientific community.

Genome editing technologies such as CRISPR/Cas9 have been developed in the last decade and have been applied to new food technologies. Genome-edited food (GEF) is a crucial issue with those new food technologies. Thus, each country has established GEF governance systems to maximize benefits and minimize risks. These emphasize the importance of communicating about GEF to the public. The key concerns are understanding various viewpoints and value perspectives (framings) in science and technology and encouraging and opening communication with the public. Thus, it is essential to understand differences between the public and experts' interests and discuss various framings and effective communication with regard to GEF. Accordingly, this study involved administering a questionnaire to analyze the public's attitudes in Japan and identify gaps between these and expert opinions on GEF. A total of 4000 responses from the public and 398 responses from GEF experts were collected. The study found that the Japanese public has a "wait-and-watch" attitude toward GEF, and the demand for basic information on it is quite high. Moreover, they are apprehensive about proper risk governance systems for GEF. This is despite experts' emphasis on the adequacy of the mechanism, necessity of technology, and trust in the scientific community. Understanding gaps between the public and experts' opinions on and interests in GEF provides essential insight for effective communication and acts as the basis for appropriate governance of emerging science and technology.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app